Showing 12 out of 2293 items
- Prevention in FocusAn overview of Canadian resources that service providers can use to understand and address harm reduction among women.
- Prevention in FocusAn overview of Canadian resources that service providers can use to understand and address HIV and hepatitis C among women.
- Study confirms that long-acting injectable HIV treatment can work in people with multiple challengesCATIE NewsInjectable HIV treatment has been found to be highly effective in clinical trials. Researchers reported results with injectable treatment in 133 people with adherence challenges. Rates of virological…
- CATIE NewsChronic viral infections such as HIV and hepatitis C can cause depression. Canadian researchers monitored 470 people co-infected with HIV and hepatitis C. After hepatitis C was cured, researchers…
This handbook offers reflexive activities and can be used as a tool for facilitating cross-agency conversations and respectful and de-stigmatizing conversations about addressing substance use.- CATIE NewsPeople with HIV are at heightened risk for heart attack and stroke. Researchers enrolled over 7,000 people with HIV who were given daily pitavastatin or placebo. Analysis found that pitavastatin…
- This “Question and Answer” booklet is for people who identify as First Nations, Inuit, and Métis, and who are imprisoned in a federal prison or in a healing lodge run by either the Correctional…
- This guide provides answers to commonly asked questions on HIV disclosure, privacy, and confidentiality in different settings, such as health care, workplaces, and universities and colleges — places…
The purpose of this primer is to mobilize health professionals and other health system stakeholders (e.g., hospital administrators, regional health authorities, governments, etc.) to take action to…- Long-acting HIV treatment in people with multiple challenges
- This report provides an overview of findings from a chart review study of coroner and medical examiner death investigations of people who died due to substance-related acute toxicity in Canada from…
- CATIE NewsThe antiviral drug tenofovir can be used to treat both HIV and hepatitis B. Researchers analysed the impact of switching from an older to a newer version of the drug. People co-infected with HIV and…